Share
Market Research Report

CANCER DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Test TypeTumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)
  • By Cancer TypeBreast Cancer · Lung Cancer · Colorectal Cancer · Melanoma · Blood Cancers · Prostate Cancer · Ovarian Cancer · Stomach Cancer · Liver Cancer · Others
  • By End UserHospital Associated Labs · Independent Diagnostic Laboratories · Diagnostic Imaging Centers · Cancer Research Institutes · Others
  • Published In27 Apr 2026
  • Report CodeCMI4029
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Cancer Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaboration
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Cancer Diagnostics Market, By Test Type, 2021 – 2033 (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Tumor Biomarkers Tests
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
        • PSA Tests
        • CTC Tests
        • AFP Tests
        • CA-19 Tests
        • HER2 Tests
        • BRCA Tests
        • ALK Tests
        • CEA Tests
        • EGFR Mutation Tests
        • KRAS Mutation Tests
        • Others
    • Imaging
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
        • Ultrasound
        • Mammography
        • MRI Scan
        • PET Scan
        • CT Scan
    • Biopsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
        • Needle Biopsy
        • Endoscopic Biopsy
        • Bone Marrow Biopsy
        • Others
    • Liquid Biopsy
    • Immunohistochemistry
    • In Situ Hybridization
  5. Global Cancer Diagnostics Market, By Cancer Type 2021 – 2033 (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Breast Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Lung Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Colorectal Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Melanoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Blood Cancers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Prostate Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Ovarian Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Stomach Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Liver Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  6. Global Cancer Diagnostics Market, By End User 2021 – 2033 (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospital Associated Labs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Independent Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Diagnostic Imaging Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Cancer Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  7. Global Cancer Diagnostics  Market, By Regions, 2021 – 2033 (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
      • Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Myriad Genetics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Invitae Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • NeoGenomics Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • BPS Bioscience
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Antibodies Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Networks LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Beckman Coulter, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Euro Diagnostica AB
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • F.Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Qiagen NV
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Siemens Healthcare GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Augurex Life Sciences Corp.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bio Rad Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Exagen Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Genway Biotech, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      •  Microdrop LLC (imaware)
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Svar Life Science AB
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bio Rad Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GE Healthcare
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Illumina, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Koninklijke Philips N.V.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Toshiba Medical Systems Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Agilent Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Aurora Imaging Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Quest Diagnostics.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 34 market data tables and 26 figures on “Global Cancer Diagnostics Market – Global forecast to 2033